MONSEY, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Wohl & Fruchter LLP announces that on July 25, 2024, it filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Zappia v. Morphic Holding, Inc. et al., Case No. 3:24-cv-04486-JD, on behalf of a class (“Class”) of individuals and entities holding the common stock of Morphic Holding, Inc. (Nasdaq: MORF) (“Morphic”), asserting claims under Sections 14(e) and 20(a) of the Securities Exchange Act of 1934, and under Delaware state law, in connection with the proposed sale of Morphic to Eli Lilly and Company via a tender offer.
Morphic investors are hereby notified that not later than 60 days after the date of this notice, any member of the purported Class may move the Court to serve as lead plaintiff of the purported Class in this action.
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please complete and submit the form on the following webpage:
https://wohlfruchter.com/cases/morphic-holding/
Alternatively, please contact us by phone at 866-833-6245, or via email at alerts@wohlfruchter.com.
About Wohl & Fruchter
Wohl & Fruchter LLP, with offices in New York City and Monsey, has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners.
Contact:
Wohl & Fruchter LLP
Joshua E. Fruchter
Toll Free 866.833.6245
alerts@wohlfruchter.com
www.wohlfruchter.com
